Kerrisdale Advisers’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,730
Closed -$227K 88
2023
Q1
$227K Sell
3,730
-165,905
-98% -$10.4M 0.07% 83
2022
Q4
$9.7M Sell
169,635
-111,168
-40% -$6.52M 2.88% 10
2022
Q3
$16.1M Buy
280,803
+54,730
+24% +$3.58M 3.92% 8
2022
Q2
$15.3M Sell
226,073
-11,986
-5% -$917K 4.8% 3
2022
Q1
$21.3M Buy
+238,059
New +$20.9M 6.52% 5
2017
Q3
Sell
-129,396
Closed -$8.59M 16
2017
Q2
$8.59M Sell
129,396
-189,300
-59% -$12M 7.91% 3
2017
Q1
$19M Buy
318,696
+70,398
+28% +$4.05M 19.63% 2
2016
Q4
$13.9M Buy
248,298
+31,070
+14% +$1.66M 13.71% 3
2016
Q3
$10.4M Sell
217,228
-121,958
-36% -$6.94M 6.73% 6
2016
Q2
$19.4M Sell
339,186
-197,055
-37% -$11.9M 5.25% 7
2016
Q1
$33.6M Buy
536,241
+220,303
+70% +$12.8M 5.74% 5
2015
Q4
$19M Sell
315,938
-17,101
-5% -$1.1M 4.85% 6
2015
Q3
$20.9M Sell
333,039
-75,577
-18% -$4.74M 6.07% 4
2015
Q2
$25M Sell
408,616
-107,245
-21% -$6.73M 8.55% 2
2015
Q1
$32.2M Buy
515,861
+86,393
+20% +$5.09M 10.58% 2
2014
Q4
$22.6M Buy
429,468
+129,456
+43% +$6.47M 11.3% 2
2014
Q3
$13.4M Buy
+300,012
New +$14.1M 6.94% 4

Other funds holding CTSH

Kerrisdale Advisers's CTSH Position: Q2 2023 in Review

Kerrisdale Advisers sold out of Cognizant (CTSH) in Q2 2023, closing a stake of 3,730 shares — an estimated $227K sold.

Kerrisdale Advisers first reported a position in CTSH in Q3 2014 and held it in 17 quarters. The position peaked at $33.6M in Q1 2016. 851 funds tracked by Wall St. Rank hold CTSH as of Q2 2023.

  • Kerrisdale Advisers reported no remaining Cognizant position as of Q2 2023 after selling out during the quarter.
  • Kerrisdale Advisers sold 3,730 Cognizant shares in Q2 2023, an estimated $227K.
  • Kerrisdale Advisers first reported a position in Cognizant in Q3 2014 and held it in 17 quarters.
  • Kerrisdale Advisers's Cognizant position peaked at $33.6M in Q1 2016.
  • 851 funds tracked by Wall St. Rank held Cognizant as of Q2 2023.

Based on Kerrisdale Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.